Global Control of Infectious Bronchitis Requires Replacing Live Attenuated Vaccines by Alternative Technologies

2021 ◽  
Vol 65 (4) ◽  
Author(s):  
Haroldo Toro
2016 ◽  
Vol 91 (5) ◽  
Author(s):  
Janet To ◽  
Wahyu Surya ◽  
To Sing Fung ◽  
Yan Li ◽  
Carmina Verdià-Bàguena ◽  
...  

ABSTRACT It has been shown previously in the severe acute respiratory syndrome coronavirus (SARS-CoV) that two point mutations, N15A and V25F, in the transmembrane domain (TMD) of the envelope (E) protein abolished channel activity and led to in vivo attenuation. Pathogenicity was recovered in mutants that also regained E protein channel activity. In particular, V25F was rapidly compensated by changes at multiple V25F-facing TMD residues located on a neighboring monomer, consistent with a recovery of oligomerization. Here, we show using infected cells that the same mutations, T16A and A26F, in the gamma-CoV infectious bronchitis virus (IBV) lead to, in principle, similar results. However, IBV E A26F did not abolish oligomer formation and was compensated by mutations at N- and C-terminal extramembrane domains (EMDs). The C-terminal EMD mutations clustered along an insertion sequence specific to gamma-CoVs. Nuclear magnetic resonance data are consistent with the presence of only one TMD in IBV E, suggesting that recovery of channel activity and fitness in these IBV E revertant mutants is through an allosteric interaction between EMDs and TMD. The present results are important for the development of IBV live attenuated vaccines when channel-inactivating mutations are introduced in the E protein. IMPORTANCE The ion channel activity of SARS-CoV E protein is a determinant of virulence, and abolishment of channel activity leads to viral attenuation. E deletion may be a strategy for generating live attenuated vaccines but can trigger undesirable compensatory mechanisms through modifications of other viral proteins to regain virulence. Therefore, a more suitable approach may be to introduce small but critical attenuating mutations. For this, the stability of attenuating mutations should be examined to understand the mechanisms of reversion. Here, we show that channel-inactivating mutations of the avian infectious bronchitis virus E protein introduced in a recombinant virus system are deficient in viral release and fitness and that revertant mutations also restored channel activity. Unexpectedly, most of the revertant mutations appeared at extramembrane domains, particularly along an insertion specific for gammacoronaviruses. Our structural data propose a single transmembrane domain in IBV E, suggesting an allosteric interaction between extramembrane and transmembrane domains.


2020 ◽  
Vol 51 (6) ◽  
pp. 621-626
Author(s):  
Lana Ljuma Skupnjak ◽  
Anto Vrdoljak ◽  
Nikol Očuršćak

The most effective means of controlling infectious bronchitis in poultry is by vaccination. Live attenuated vaccines based on the H120 strain (Mass serotype) are the most commonly used vaccines. Since vaccination is often performed in the hatchery, long duration of immunity is preferred. Avishield IB H120, a live attenuated vaccine based on the strain H120 is registered across the European Union and other countries, and has a declared immunity period of up to 5 weeks after vaccination. This study presents the results of an additional survey demonstrating protection against challenge with the IBV strain M41 up to 8 weeks after a single vaccination with Avishield IB H120. Seven weeks after vaccination, 94% of chickens vaccinated by spray were protected against the challenge. Eight weeks after vaccination, 80% of spray vaccinated chickens and 75% of orally vaccinated chickens were still protected against the challenge with virulent IBV.


Animals ◽  
2020 ◽  
Vol 10 (11) ◽  
pp. 2058
Author(s):  
Miguel Guzmán ◽  
Héctor Hidalgo

Infectious bronchitis virus (IBV) remains one of the most important diseases impacting poultry today. Its high adaptive capacity, attributable to the high mutation rate associated with its ssRNA(+), is one of its more important features. While biosecurity procedures and barriers have been shown to be preponderant factors in minimizing the impact of infectious bronchitis (IB), the environment and procedures associated with intensive poultry systems greatly influence the viral population dynamics. High-density poultry flocks facilitate recombination between different viruses, and even with live attenuated vaccines, which can change the dominant circulating field strains. Furthermore, the remaining issue of reversion to virulence gives rise to significant problems when vaccinal strains are introduced in places where their pathogenic variants have not been reported. Under specific conditions, live attenuated vaccines could also change the frequency of circulating viruses and enable replacement between different field strains. In summary, under a comprehensive approach, while vaccination is one of the most essential tools for controlling IB, the veterinarians, farmers, and official services role in its usage is central to minimizing alteration in a malleable viral population. Otherwise, vaccination is ultimately counterproductive.


Vaccines ◽  
2021 ◽  
Vol 9 (5) ◽  
pp. 531
Author(s):  
Sabrina M. M. Buharideen ◽  
Mohamed S. H. Hassan ◽  
Shahnas M. M. Najimudeen ◽  
Dongyan Niu ◽  
Markus Czub ◽  
...  

For decades, vaccinations have been used to limit infectious bronchitis (IB) in both the broiler and layer industries. Depending on the geographical area, live attenuated vaccines are used either alone or in combination with inactivated vaccines to control infectious bronchitis virus (IBV) infections. It has been shown that administering inactivated vaccines preceded by priming with live attenuated vaccines in pullets protects laying hens against IB. However, the immunological basis of this protective response has not been adequately investigated. The objective of the study was to compare two vaccination strategies adapted by the Canadian poultry industry in terms of their ability to systemically induce an adequate immune response in IBV-impacted tissues in laying hens. The first vaccination strategy (only live attenuated IB vaccines) and second vaccination strategy (live attenuated and inactivated IB vaccines) were applied. Serum anti-IBV antibodies were measured at two time points, i.e., 3 weeks and 10 weeks post last vaccination. The recruitment of T cell subsets (i.e., CD4+ and CD8+ T cells), and the interferon (IFN)-γ mRNA expression were measured at 10 weeks post last vaccination. We observed that vaccination strategy 2 induced significantly higher serum anti-IBV antibody responses that were capable of neutralizing an IBV Mass variant associated with a flock history of shell-less egg production better than a Delmarva (DMV)1639 variant, as well as a significantly higher IFN-γ mRNA expression in the lungs, kidneys, and oviduct. We also observed that both vaccination strategies recruited CD4+ T cells as well as CD8+ T cells to the examined tissues at various extents. Our findings indicate that vaccination strategy 2 induces better systemic and local host responses in laying hens.


2018 ◽  
Vol 6 (3) ◽  
Author(s):  
Arie Herlambang

Clean water to poor communities who live in crowded municipal area is stillexpensive and a luxury. This condition is evidenced by the number of people whouse ground water for their daily water, because water taps still seems expensivefor them. Diarrheal disease is still relatively high for Indonesia, where nearly 16thousand people suffer from diarrhea due to poor sanitation. To help the poor inthe city, there are several alternative technologies that can be applied to publicaccess to clean water and adequate low-cost, including ground water treatmenttechnology with a filter system equipped with an ultraviolet sterilizer, or ozonegenerators, or using ultrafiltration, if possible can also use the reverse osmosismembrane that for fresh water. Arsinum is the best alternative should be chosenfor fulfilled potable water in slump area.Keywords : Sanitation, water treatment technology, portable water, low-cost, slump area


Infectious bronchitis of chickens (IBC) is a highly contagious disease characterized by damage to the respiratory tract. Adult chickens exhibit respiratory symptoms, a 10-50% decrease in egg production, discoloration of the eggshell, deformation of the shell, and a deterioration in the marketability and breeding quality of eggs. The circulation of variant strains in poultry farms of the Russian Federation causes a significant decrease in egg production and the quality of the eggs obtained, causing significant economic damage to industrial poultry farming. The study aimed to presents materials and methods for the industrial and efficient use of live-vaccines against infectious bronchitis of hens from a variant strain. After the use of a live vaccine against infectious bronchitis of chickens from a variant strain, the development, live weight of chickens, and feed conversion during the rearing period were within the standard parameters. in present study, the safety for the growing period with a planned 97.6% was 98.8-98.9%. The uniformity of the herds when transferred to hen - hen was 94-95%. When carrying out immunoprophylaxis of IBS, local immunity is important, which can be ensured using a live spray vaccine - a method starting from the day old. When establishing circulation in the economy of variant strains of IBC virus, it is necessary to introduce vaccination against the variant strain into the scheme of treatment and preventive measures. The research results allow us to conclude that, for the effective prevention of chicken infectious bronchitis, immunization against IBS from variant strains should be introduced into the vaccine prevention scheme.


Sign in / Sign up

Export Citation Format

Share Document